Search research articles
Contact Us
Filters
Showing results (131-140 of 178) with videos related to
Page
of 18
Sort By:
Journal of the American College of Cardiology
|
October 1, 1989
Painless exercise ST deviation on the treadmill: long-term prognosis
D B Mark, M A Hlatky, R M Califf, et al.
Journal of the American College of Cardiology
|
April 1, 1988
Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty
C A Simonton, D B Mark, T Hinohara, et al.
Journal of Aging and Health
|
June 10, 2000
The relationship between self-rated health and health status among coronary artery patients
H B Bosworth, I C Siegler, B H Brummett, et al.
The American Journal of Cardiology
|
December 15, 1990
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group
T C Wall, R M Califf, L Harrelson-Woodlief, et al.
The American Journal of Cardiology
|
December 30, 1999
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)
C J Pepine, D B Mark, M G Bourassa, et al.
The New England Journal of Medicine
|
August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
L Pilote, R M Califf, S Sapp, et al.
The New England Journal of Medicine
|
January 9, 1997
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators
M A Hlatky, W J Rogers, I Johnstone, et al.
The New England Journal of Medicine
|
May 25, 1995
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
D B Mark, M A Hlatky, R M Califf, et al.
Circulation
|
February 2, 2000
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes
D B Mark, R A Harrington, A M Lincoff, et al.
The American Journal of Cardiology
|
November 15, 1995
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group
A Barbagelata, C B Granger, E J Topol, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 178) with videos related to
Sort By:
Page
of 18
Journal of the American College of Cardiology
|
October 1, 1989
Painless exercise ST deviation on the treadmill: long-term prognosis
D B Mark, M A Hlatky, R M Califf, et al.
Journal of the American College of Cardiology
|
April 1, 1988
Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty
C A Simonton, D B Mark, T Hinohara, et al.
Journal of Aging and Health
|
June 10, 2000
The relationship between self-rated health and health status among coronary artery patients
H B Bosworth, I C Siegler, B H Brummett, et al.
The American Journal of Cardiology
|
December 15, 1990
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group
T C Wall, R M Califf, L Harrelson-Woodlief, et al.
The American Journal of Cardiology
|
December 30, 1999
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)
C J Pepine, D B Mark, M G Bourassa, et al.
The New England Journal of Medicine
|
August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
L Pilote, R M Califf, S Sapp, et al.
The New England Journal of Medicine
|
January 9, 1997
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators
M A Hlatky, W J Rogers, I Johnstone, et al.
The New England Journal of Medicine
|
May 25, 1995
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
D B Mark, M A Hlatky, R M Califf, et al.
Circulation
|
February 2, 2000
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes
D B Mark, R A Harrington, A M Lincoff, et al.
The American Journal of Cardiology
|
November 15, 1995
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group
A Barbagelata, C B Granger, E J Topol, et al.
Page
of 18